These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 21280534)
1. Probing and syringing with 3% solution of NaCl and/or 0.2 mg/ml mitomycin-C in nasolacrimal duct obstruction patients. Choontanom R J Med Assoc Thai; 2010 Nov; 93 Suppl 6():S197-202. PubMed ID: 21280534 [TBL] [Abstract][Full Text] [Related]
2. [Treatment of nasolacrimal duct obstruction with probing in children younger than 4 years]. Mrugacz M; Sielicka D; Bakunowicz-Łazarczyk A Klin Oczna; 2010; 112(7-9):221-2. PubMed ID: 21121125 [TBL] [Abstract][Full Text] [Related]
3. Nonlaser endoscopic endonasal dacryocystorhinostomy with adjunctive mitomycin C in nasolacrimal duct obstruction in adults. Dolmetsch AM Ophthalmology; 2010 May; 117(5):1037-40. PubMed ID: 20079535 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of probing with mitomycin-C in adults with primary acquired nasolacrimal duct obstruction. Sinha MK; Bajaj MS; Pushker N; Ghose S; Chandra M J Ocul Pharmacol Ther; 2013 Apr; 29(3):353-5. PubMed ID: 23145864 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of probing the nasolacrimal duct with adjunctive Mitomycin-C for epiphora in adults. Tsai CC; Kau HC; Kao SC; Hsu WM; Liu JH Ophthalmology; 2002 Jan; 109(1):172-4. PubMed ID: 11772600 [TBL] [Abstract][Full Text] [Related]
6. Silicone nasolacrimal intubation with mitomycin-C: a prospective, randomized, double-masked study. Liu D; Bosley TM Ophthalmology; 2003 Feb; 110(2):306-10. PubMed ID: 12578771 [TBL] [Abstract][Full Text] [Related]
7. Nasolacrimal intubation with mitomycin C. Boboridis K; Ziakas N; Georgiadis N Ophthalmology; 2004 Feb; 111(2):416-7; author reply 417. PubMed ID: 15019414 [No Abstract] [Full Text] [Related]
8. Success of probing for congenital nasolacrimal duct obstruction in children under 10 years of age. Thongthong K; Singha P; Liabsuetrakul T J Med Assoc Thai; 2009 Dec; 92(12):1646-50. PubMed ID: 20043568 [TBL] [Abstract][Full Text] [Related]
9. An investigation into the efficacy of probing the nasolacrimal duct as a treatment for epiphora in adults. Bell TA Trans Ophthalmol Soc U K (1962); 1986; 105 ( Pt 4)():494-7. PubMed ID: 3466472 [TBL] [Abstract][Full Text] [Related]
13. Balloon catheter dilatation versus probing as primary treatment for congenital dacryostenosis. Goldich Y; Barkana Y; Zadok D; Avni I; Pras E; Mezer E; Morad Y Br J Ophthalmol; 2011 May; 95(5):634-6. PubMed ID: 20935303 [TBL] [Abstract][Full Text] [Related]
14. Dacryostenosis in newborns: probing, or syringing, or both? Tahat AA Eur J Ophthalmol; 2000; 10(2):128-31. PubMed ID: 10887923 [TBL] [Abstract][Full Text] [Related]
15. Outcome of probing under topical anesthesia in children below 18 months of age with congenital nasolacrimal duct obstruction. Shrestha JB; Bajimaya S; Hennig A Nepal Med Coll J; 2009 Mar; 11(1):46-9. PubMed ID: 19769238 [TBL] [Abstract][Full Text] [Related]
16. Epiphora as a side effect of topical mitomycin C. Kopp ED; Seregard S Br J Ophthalmol; 2004 Nov; 88(11):1422-4. PubMed ID: 15489486 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of mitomycin C in endonasal endoscopic dacryocystorhinostomy. Tirakunwichcha S; Aeumjaturapat S; Sinprajakphon S Laryngoscope; 2011 Feb; 121(2):433-6. PubMed ID: 21271601 [TBL] [Abstract][Full Text] [Related]
18. The anatomy of probing and irrigation for congenital nasolacrimal duct obstruction. Zwaan J Ophthalmic Surg Lasers; 1997 Jan; 28(1):71-3. PubMed ID: 9031311 [TBL] [Abstract][Full Text] [Related]
19. Treatment of congenital nasolacrimal duct obstruction before and after the age of 1 year. Zwaan J Ophthalmic Surg Lasers; 1997 Nov; 28(11):932-6. PubMed ID: 9387181 [TBL] [Abstract][Full Text] [Related]